Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0012739 (
disseminated intravascular coagulation
)
8,673
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Prothrombin time (PT) is widely utilized for evaluation of diseases with single or multiple coagulation factors disorders, such as severe liver dysfunction and
disseminated intravascular coagulation
(
DIC
). However, its standardization of reagent and method is not established yet for universal purpose except International Normalized Ratio (INR) for control of oral anticoagulant therapy (OAT). Neither Prothrombin time ratio adapted in Japanese criteria for
DIC
nor seconds method in criteria reported by the last SSC meeting is corrected between assays, therefore much dependence on these criteria causes risk of misdiagnosis. In order to resolve
incoherence
of method of PT, we performed this study for introducing INR method to diagnostic criteria for
DIC
. In our results, sensitivities of two reagents from human tissue factor (TF) to
DIC
model plasma with middle to low activities of multiple coagulation factors almost equal to plasma from patients with OAC, although other two reagents from rabbit TF show discrepancy of sensitivities between
DIC
and OAT plasma. These suggest a potentiality to introduce INR system to diagnosis of
DIC
when human TF is used as a PT reagent. Based on standardization of method, significance of PT in
DIC
criteria should be reevaluated in worldwide.
...
PMID:[Prothrombin time and its standardization: a potentiality to introduce INR method in criteria for disseminated intravascular coagulation]. 1198 56